Podbit · The Peter Attia Drive
Melatonin doesn't knock you out — it tells your brain what time it is. The optimal dose to shorten sleep latency is just 4 mg, yet most people take 5–10 mg, which can backfire by disrupting circadian alignment. And commercial product accuracy is so poor that actual content can range from 80% below to nearly 500% above the label claim.
Where this was said
At 35:50 · chapter starts 27:15
During slow-wave sleep, the brain's glymphatic system activates — neurons shrink slightly, opening about 60% more interstitial space, allowing CSF to circulate freely and carry away metabolic toxins including beta-amyloid and aberrant tau proteins implicated in Alzheimer's disease. Animal studies show glymphatic amyloid clearance roughly doubles during sleep, especially deep slow-wave sleep. Human studies confirm that even a single night of sleep deprivation impairs this clearance, and chronic disruption correlates with long-term amyloid and tau burden. The accumulation of these proteins in turn damages the brain regions that regulate sleep, creating a vicious cycle. Researcher David Holtzman suspected an orexin-amyloid link, since both orexin levels and CSF amyloid follow similar diurnal rhythms. His group infused orexin into mouse hippocampi and found it raised interstitial amyloid; the early DORA almorexant lowered it. Dayvigo in tau-mutant mice slowed tau pathology and brain atrophy in male mice. In a landmark 2023 human trial of 38 adults aged 45–65, 20 mg of Belsomra — but not 10 mg — reduced CSF amyloid-beta by ~20%. Ambien had no such effect. This specificity is critical: simple unconsciousness isn't doing the clearing. Three new clinical trials — two with ~200 subjects each — are underway and expected to report between now and 2029.
DORAs work by dialing down the brain's orexin-driven wakefulness system rather than forcing sedation — a fundamentally different mechanism that preserves sleep architecture and even improves REM sleep. Meta-analyses show superior sleep efficiency and tolerability compared to older drug classes.
The brain's glymphatic waste-clearance system — which flushes amyloid and tau during deep sleep — roughly doubles its clearance rate during slow-wave sleep. DORAs preserve that architecture, and a 2023 human trial found 20 mg of suvorexant reduced CSF amyloid-beta by about 20%. The data are early but the signal is strong enough to warrant close attention.
During sleep, neurons shrink slightly, opening about 60% more interstitial space, allowing the glymphatic system to flush beta-amyloid and tau proteins from the brain.
Animal studies show glymphatic clearance of beta-amyloid roughly doubles during sleep, particularly during deep non-REM slow-wave sleep.
In a 2023 human trial, 20 mg of suvorexant (Belsomra) decreased CSF amyloid-beta by roughly 20% starting about 5 hours after administration.
Self-help fails because people are sold one universal cure by the hyper-responders who had a transformative result from it. The real problem is context: every method works for the right person at the right time, which is almost never you just because the author says so.
Spencer Greenberg was once so socially anxious his heart pounded just approaching a stranger. His therapist gave him homework: go to a bar alone, talk to 5 strangers. Starting with asking for the time, he worked up to asking men for hugs — and his anxiety fell dramatically in 6 months.
A person who flies regularly but obsessively checks weather forecasts before every flight is not doing exposure therapy — they're teaching their brain that flying is only safe with the ritual. Safety behaviors prevent the brain from ever learning that the feared thing is actually fine.
The worry-time technique assigns all worries to one scheduled slot (e.g. 5 PM). Every time a worry surfaces, you write it down and ban yourself from engaging with it until that time. When 5 PM arrives, most worries feel trivial and the act of batch-worrying exposes how little it actually accomplishes.
In a randomized study of 20 habit techniques, 'habit reflection' stood out: recall a past habit you successfully built, write down what helped you succeed, then apply those same strategies to your new habit. It works because it's self-adapting — it uses whatever worked for YOU.
The tiny habits technique — always having a minimal version of your habit you can do when life gets in the way — keeps the mental machinery of habit formation from breaking. Paradoxically, people given a tiny-habit fallback option were MORE successful at the full habit, not less.
Fears and worries act like playground bullies — they want to ambush you. But when you deliberately seek them out and choose the time of engagement, they lose their power. The volitional act of starting the fight on your own terms is one of CBT's most underappreciated insights.
Most downtime defaults are things you regret immediately after — phone scrolling, binge TV. 'Glad you did it' activities meet the same need for rest but leave you feeling like you spent your time well. The switch from a bad screen to a documentary, a book, or a walk costs almost no extra effort but compounds into identity over time.
You rarely control your first reactive thought. But you can train your second thought — the response to the trigger — by asking whether your initial reaction is the most helpful one and replacing it with something equally true but more constructive. Over time, that second thought becomes automatic.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.